US Patent 12,357,586 — assignment history and current owner
US 12,357,586 · Application 17/585,415
Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy
Who owns US Patent 12,357,586?
US12357586 ("Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy") — current assignee: JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. Status: Active, estimated expiration January 3, 2032. 5 recorded USPTO assignments.
Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,357,586 is JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. Based on the most recent name change record (recorded 2025-04-11).
- Patent title
- Use Of The Phytocannabinoid Cannabidiol (cbd) In Combination With A Standard Anti-epileptic Drug (saed) In The Treatment Of Epilepsy
- Application number
- 17/585,415
- Apparent operating assignee
- JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED
- Patent status
- Active, estimated expiration January 3, 2032
- Recorded assignments
- 5
Note: a security interest appears active (U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE) with no recorded release. Security interests reflect financing arrangements, not operating ownership.
Recorded assignment history
| Executed | Recorded | Conveyance | Assignor(s) | Assignee(s) | Reel/frame |
|---|---|---|---|---|---|
| Feb 7, 2023 | May 12, 2023 | Ownership Transfer | OTSUKA PHARMACEUTICAL CO., LTD. | GW PHARMA LTD. | 63631/588 |
| Dec 2, 2011 | Aug 11, 2023 | Ownership Transfer | STEPHENS, GARY; WHALLEY, BEN; WILLIAMS, CLAIRE | GW PHARMA LIMITED; OTSUKA PHARMACEUTICAL CO. LIMITED | 64567/274 |
| Jul 24, 2024 | Jul 26, 2024 | Security Agreement | CAVION, INC.; CELATOR PHARMACEUTICALS, INC.; GW PHARMA LIMITED; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (F/K/A GW RESEARCH LIMITED); JAZZ PHARMACEUTICALS, INC. | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE | 68173/155 |
| Nov 20, 2023 | Jan 21, 2025 | Name Change | GW RESEARCH LIMITED | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED | 69945/331 |
| Sep 12, 2024 | Apr 11, 2025 | Name Change | GW PHARMA LIMITED | JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED | 70817/264 |
Scrolls sideways on narrow screens
Chain of title
In 2023, OTSUKA PHARMACEUTICAL CO., LTD. assigned the patent to GW PHARMA LTD.. The most recent ownership transfer, recorded in 2023, lists GW PHARMA LIMITED; OTSUKA PHARMACEUTICAL CO. LIMITED as assignee. In 2025, GW PHARMA LIMITED changed its name to JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED. In 2024, U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.
Apparent recorded rights summary — disclaimer
This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.
Ownership settled? Give your AI the file.
Application 17/585,415 · US 12,357,586
The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,357,586, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.